Maternal Plasma 25-Hydroxyvitamin D Concentrations and the Risk for Gestational Diabetes Mellitus

Background Evidence is accumulating for a role of vitamin D in maintaining normal glucose homeostasis. However, studies that prospectively examined circulating concentrations of 25-hydroxyvitamin D (25-[OH] D) in relation to diabetes risk are limited. Our objective is to determine the association between maternal plasma 25-[OH] D concentrations in early pregnancy and the risk for gestational diabetes mellitus (GDM). Methods A nested case-control study was conducted among a prospective cohort of 953 pregnant women. Among them, 57 incident GDM cases were ascertained and 114 women who were not diagnosed with GDM were selected as controls. Controls were frequency matched to cases for the estimated season of conception of the index pregnancy. Results Among women who developed GDM, maternal plasma 25-[OH] D concentrations at an average of 16 weeks of gestation were significantly lower than controls (24.2 vs. 30.1 ng/ml, P<0.001). This difference remained significant (3.62 ng/ml lower on average in GDM cases than controls (P value = 0.018)) after the adjustment for maternal age, race, family history of diabetes, and pre-pregnancy BMI. Approximately 33% of GDM cases, compared with 14% of controls (P<0.001), had maternal plasma 25-[OH] D concentrations consistent with a pre-specified diagnosis of vitamin D deficiency (<20 ng/ml). After adjustment for the aforementioned covariates including BMI, vitamin D deficiency was associated with a 2.66-fold (OR (95% CI): 2.66 (1.01–7.02)) increased GDM risk. Moreover, each 5 ng/ml decrease in 25-[OH] D concentrations was related to a 1.29-fold increase in GDM risk (OR (95% CI): 1.29 (1.05–1.60)). Additional adjustment for season and physical activity did not change findings substantially. Conclusions Findings from the present study suggest that maternal vitamin D deficiency in early pregnancy is significantly associated with an elevated risk for GDM.

[1]  C. Fall,et al.  Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size , 2009, European Journal of Clinical Nutrition.

[2]  E. Giovannucci Vitamin D and cancer incidence in the Harvard cohorts. , 2009, Annals of epidemiology.

[3]  N. Wareham,et al.  Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance , 2008, Diabetes.

[4]  P. McElduff,et al.  Maternal vitamin D deficiency, ethnicity and gestational diabetes , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[5]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[6]  B. Larijani,et al.  Correlation between vitamin D3 deficiency and insulin resistance in pregnancy , 2008, Diabetes/metabolism research and reviews.

[7]  M. Holick,et al.  Maternal vitamin D deficiency increases the risk of preeclampsia. , 2007, The Journal of clinical endocrinology and metabolism.

[8]  A. Mitrakou,et al.  The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults , 2007, Diabetes Care.

[9]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[10]  L. Bodnar,et al.  High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. , 2007, The Journal of nutrition.

[11]  C. Wagner,et al.  Nutritional vitamin D status during pregnancy: reasons for concern , 2006, Canadian Medical Association Journal.

[12]  E. Warburton,et al.  Reduced Vitamin D in Acute Stroke , 2006, Stroke.

[13]  B. Boucher,et al.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. , 2004, The American journal of clinical nutrition.

[14]  M. Sowers,et al.  Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. , 2004, Diabetes care.

[15]  M. Thompson,et al.  Maternal Plasma Ascorbic Acid (Vitamin C) and Risk of Gestational Diabetes Mellitus , 2004, Epidemiology.

[16]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. , 2004, The American journal of clinical nutrition.

[17]  I-Min Lee,et al.  Prospective study of gestational diabetes mellitus risk in relation to maternal recreational physical activity before and during pregnancy. , 2004, American journal of epidemiology.

[18]  S. Adami,et al.  High prevalence of hypovitaminosis D in female type 2 diabetic population. , 2001, Diabetes care.

[19]  T. Schermerhorn,et al.  Calbindin-D(28k) controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines. , 1999, The Journal of biological chemistry.

[20]  P. Froom,et al.  Association of calcitriol and blood pressure in normotensive men. , 1997, Hypertension.

[21]  E. Feskens,et al.  Vitamin D, glucose tolerance and insulinaemia in elderly men , 1997, Diabetologia.

[22]  C. Hales,et al.  Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians , 1995, Diabetologia.

[23]  L. Lind,et al.  Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. , 1995, American journal of hypertension.

[24]  M. Riddle,et al.  Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. , 1994, The American journal of clinical nutrition.

[25]  J. Devlin Effects of Exercise on Insulin Sensitivity in Humans , 1992, Diabetes Care.

[26]  R. Mak,et al.  Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. , 1992, Kidney international.

[27]  R. Beaglehole,et al.  Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. , 1990, International journal of epidemiology.

[28]  L. Lind,et al.  Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. , 1989, Diabetes research.

[29]  R. Eckel,et al.  Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. , 1988, The Journal of clinical investigation.

[30]  A. Norman,et al.  Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. , 1987, Endocrinology.

[31]  O. Gedik,et al.  Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man , 1986, Diabetologia.

[32]  H. DeLuca,et al.  Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. , 1983, Endocrinology.

[33]  G. Grodsky,et al.  Vitamin D deficiency inhibits pancreatic secretion of insulin. , 1980, Science.

[34]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[35]  C. Dent,et al.  PLASMA 25-HYDROXYVITAMIN-D LEVELS DURING PREGNANCY IN CAUCASIANS AND IN VEGETARIAN AND NON-VEGETARIAN ASIANS , 1975, The Lancet.

[36]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[37]  N. Wareham,et al.  Baseline serum 25-hydroxy vitamin D is predictive of future glycaemic status and insulin resistance : The MRC Ely prospective study 1990 – 2000 , 2008 .

[38]  B. Kestenbaum,et al.  Calcium plus vitamin D supplementation and the risk of incident diabetes mellitus in the Women ’ s Health Initiative , 2008 .

[39]  G. Tenderich,et al.  Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? , 2003, Journal of the American College of Cardiology.